Opinion
Published on 12 Aug 2024
Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as the source animal
in Cancer Immunity and Immunotherapy
![Missed opportunities to increase efficiency of monoclonal antibody development using hybridoma technology and mice as the source animal](https://www.frontiersin.org/files/myhome article library/1443726/1443726_Thumb_400.jpg)
- 152 views
Opinion
Published on 12 Aug 2024
in Cancer Immunity and Immunotherapy
Review
Published on 12 Aug 2024
in Molecular and Cellular Pathology
Original Research
Published on 12 Aug 2024
in Pulmonary Medicine
Original Research
Published on 12 Aug 2024
in Nanobiotechnology
Review
Published on 12 Aug 2024
in General Cardiovascular Medicine
Editorial
Published on 12 Aug 2024
in Strengthening Rehabilitation in Health Systems
Original Research
Published on 12 Aug 2024
in Cancer Immunity and Immunotherapy
Editorial
Published on 12 Aug 2024
in Contraception and Family Planning
Review
Published on 12 Aug 2024
in Cancer Metabolism
Original Research
Published on 12 Aug 2024
in Industrial Biotechnology
Brief Research Report
Published on 12 Aug 2024
in Elite Sports and Performance Enhancement
Original Research
Published on 12 Aug 2024
in Educational Psychology
Case Report
Published on 12 Aug 2024
in Nutrition, Psychology and Brain Health
Clinical Trial
Published on 12 Aug 2024
in Ophthalmology
Original Research
Published on 12 Aug 2024
in Learning and Memory
Original Research
Published on 12 Aug 2024
in Pharmacology of Anti-Cancer Drugs